SEARCH

SEARCH BY CITATION

References

  • 1
    2000 AHA Heart and Stroke Statistical Update. American Heart Association Web site. Available at: http://www.americanheart.org/statistics/hb.html. Accessed November 1,2000.
  • 2
    JNC VI. The sixth report of the Joint National Committee on the Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI). Arch Intern Med. 1997;157:24132446.
  • 3
    Guidelines Subcommittee 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertens. 1999;17:151183.
  • 4
    Ramsay LE, Williams B, MacGregor GA, et al. Guidelines for the management of hypertension: report of the third working party of the British Hypertension Society. J Hum Hypertens. 1999:569592.
  • 5
    Burt VL, Whelton P, Roccella EJ, et al. Prevalence of hypertension in the U.S. adult population: results from the Third National Health and Nutrition Examination Survey, 1988–1991. Hypertension. 1995;25:305313.
  • 6
    National Center for Health Statistics. NHANES III data. Hyattsville, MD: U.S. Public Health Service; 1997.
  • 7
    National High Blood Pressure Educational Program working group. National High Blood Pressure Education Program report on hypertension in the elderly. Hypertension. 1994;23:275285.
  • 8
    Franklin SS, Jacobs MJ, Wong ND, et al. The predominance of isolated systolic hypertension among middle-aged and elderly U.S. hypertensives—an analysis based on NHAHES III. Hypertension. In press.
  • 9
    O'Conner PJ, Quiter ES, Rush WA, et al. Impact of hypertension guidelines implementation on blood pressure control and drug use in primary care clinics. J Quality Improvement. 1999;2:268277.
  • 10
    Berlowitz DR, Ash AS, Hickey EC, et al. Inadequate management of blood pressure in a hypertensive population. N Engl J Med. 1998;339:19571963.
  • 11
    Alexander M, Tekawa I, Hunkeler E, et al. Evaluating hypertension control in a managed care setting. Arch Intern Med. 1999;159:26732677.
  • 12
    Paramore LC, Halpern MT, Lapuerta P, et al. The impact of poorly controlled hypertension on healthcare resource utilization and cost. Am J Managed Care. 2001;7:389398.
  • 13
    Hyman DJ, Pavlick VN. Self-reported hypertension treatment practices among primary care physicians. Arch Intern Med. 2000;160:22812286.
  • 14
    Oliveria S, Lapuerta P, McCarthy B, et al. Physician knowledge and barriers to the effective management of uncontrolled Hypertension. Circulation. 2000;102:4108.
  • 15
    Asch SM, Kerr EA, Lapuerta P, et al. A new approach for measuring quality of care for women with hypertension. Arch Intern Med. In press.
  • 16
    Lloyd-Jones DM, Evans JC, Larson MG, et al. Differential control of systolic and diastolic blood pressure: factors associated with lack of blood pressure control in the community. Hypertension. 2000;36:594599.
  • 17
    Burt VL, Cutler JA, Higgins M, et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult U.S. population. Hypertension. 1995;26:6069.
  • 18
    Cushman WC. The clinical significance of systolic hypertension. Am J Hypertens. 1998;11;182S185S.
  • 19
    O'Donnell CJ, Kannel WB. Cardiovascular risks of hypertension: Lessons from observational studies. J Hypertens. 1998;16(suppl 6):S3S7.
  • 20
    Ogden LG, Jiang H, Lydick E, et al. Long-term absolute benefit of lowering blood pressure in hypertensive patients according to the JNC-VI risk stratification. Hypertension. 2000;35:539543.
  • 21
    Izzo JI, Levy D, Black HR. Clinical advisory statement: importance of systolic blood pressure in older Americans. Hypertension. 2000;35:10211024.
  • 22
    Hansson L, Zsancheth A, Caruthers SG, et al., on behalf of the HOT Study Group. Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: principle results of the Hypertension Optimal Treatment (HOT) trial. Lancet. 1998;351:17551762.
  • 23
    Black HR, Elliot WG, Neaton JD, et al. Baseline characteristics of the 16,605 patients in the CONVINCE study. J Hypertens. 1999;17:S201.
  • 24
    Cushman WC, Black HR, Probstfield, JL; et al., for the ALLHAT Research Group. Blood pressure control in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) [abstract]. Am J Hypertens. 1998;11:17A.
  • 25
    Swales JD. Current clinical practice in hypertension: the EISBERG (Evaluation and Intervention for Systolic Blood Pressure Elevation—Regional and Global) project. Am Heart J. 1999;138:S231S237.
  • 26
    Shah BV, Barnwell BG, Bieler GS. SUDAAN Users' Manual. Release 7.5, Research Triangle Park. Cary, NC: Research Triangle Institute; 1997.
  • 27
    SAS Institute. SAS Procedures Guide, version 6.12. 3rd ed, Cary, NC: SAS Institute; 1995.
  • 28
    Population Estimates Program, Population Division, U.S. Census Bureau. Internet release date: April 11, 2000 Revised date: June 28, 2000. Available at: http://www.census.gov/population/www/estimates/uspop.html. Accessed December 1, 2000.
  • 29
    Jackson EA, Buring JE, Ridker PM, et al. Borderline isolated systolic hypertension and risk of cardiovascular disease in women [abstract]. Paper presented at: 40th Annual Conference on Cardiovascular Disease Epidemiology and Prevention; March 2, 2000; San Diego, CA.
  • 30
    Lapuerta P, L'Italien GJ. Awareness, treatment and control of blood pressure in the United States. J Hypertens. 1999;17(suppl3):S188.